T-Cypher Bio - Crunchbase Company Profile & Funding

Q: Who invested in T-Cypher Bio?

T-Cypher Bio has 2 investors including Oxford Science Enterprises And Future Planet Capital.

Q: When was the last funding round for T-Cypher Bio?

T-Cypher Bio closed its last funding round on obfuscated from a Seed round.

Overview

T-Cypher Bio

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About T-Cypher Bio

CB Rank

263417

T-Cypher Bio is an early-stage biotechnology company.

Founded

obfuscation

Private

Seed

Oxford, Oxfordshire, United Kingdom

1-10

tcypherbio.com/

Biotechnology

Funding Rounds

Seed

OBF

obfuscation

Key People

Thomas Lars Andresen: Chief Executive Officer
Past Role: LiPlasome Pharma, Head Of R&D

Details

Legal Name

T-Cypher Bio Limited

Operating Status

Active

Company Type

For Profit

Founders

Graham Ogg

About the Company

T-Cypher Bio is an early-stage biotechnology company. T-Cypher Bio we believe that TCR-based therapeutics have the potential to transform the treatment of solid tumors, as well as autoimmune, inflammatory, and infectious diseases. Yet challenges in the identification of therapeutically relevant targets and TCRs have limited the application of such

therapies. T-Cypher’s integrated platform, D-Cypher, overcomes these challenges.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

TCR-based Therapeutics

Develops novel therapeutics based on T cell receptors (TCRs) to treat immune-mediated diseases.

High-Throughput Immune Profiling

Provides high-resolution profiling of the immune synapse to map intracellular targets and profile T cell specificity.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - T-Cypher Bio	2	obfuscated obfuscation	Oxford Science Enterprises	Seed
obfuscated obfuscation	Seed Round - T-Cypher Bio	2	obfuscated obfuscation	Oxford Science Enterprises	Seed
obfuscated obfuscation	Seed Round - T-Cypher Bio	2	obfuscated obfuscation	Oxford Science Enterprises	Seed
obfuscated obfuscation	Seed Round - T-Cypher Bio	2	obfuscated obfuscation	Oxford Science Enterprises	Seed
obfuscated obfuscation	Seed Round - T-Cypher Bio	2	obfuscated obfuscation	Oxford Science Enterprises	Seed

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - T-Cypher Bio	2	obfuscated obfuscation	Oxford Science Enterprises	Seed
obfuscated obfuscation	Seed Round - T-Cypher Bio	2	obfuscated obfuscation	Oxford Science Enterprises	Seed
obfuscated obfuscation	Seed Round - T-Cypher Bio	2	obfuscated obfuscation	Oxford Science Enterprises	Seed
obfuscated obfuscation	Seed Round - T-Cypher Bio	2	obfuscated obfuscation	Oxford Science Enterprises	Seed
obfuscated obfuscation	Seed Round - T-Cypher Bio	2	obfuscated obfuscation	Oxford Science Enterprises	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Oxford Science Enterprises	Yes	Seed Round - T-Cypher Bio	Uciane Scarlett
Oxford Science Enterprises	Yes	Seed Round - T-Cypher Bio	Uciane Scarlett
Oxford Science Enterprises	Yes	Seed Round - T-Cypher Bio	Uciane Scarlett
Oxford Science Enterprises	Yes	Seed Round - T-Cypher Bio	Uciane Scarlett
Oxford Science Enterprises	Yes	Seed Round - T-Cypher Bio	Uciane Scarlett